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Apoptosis Meets Signal Minireview
Transduction: Elimination
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The Bcl-2 family consists of a growing number of mole-
cules that, perhaps paradoxically, can either promote
Introduction survival or augment programmed cell death (Table 1).
Apoptotic cell death is a critical feature of the regulated A striking feature of the Bcl-2 family members is their
development of multicellular organisms. An individual ability to dimerize. The pro-apoptotic member Bad can
cell must integrate signals delivered by death-inducing dimerize with Bcl-2 and Bcl-xL, and overexpression of
and survival-promoting receptors to determine its fate Bad counters the survival-promoting effect of Bcl-2 and
in the context of the organism as a whole. A major focus Bcl-xL. Bax also forms heterodimers with Bcl-2 and Bcl-
on the regulation of apoptosis has been onthe identifica- xL, although apparently with lower affinity than does
tion of new molecules that influence cell survival ineither Bad. The ratio of Bcl-2 to Bax appears to determine
a positive or a negative fashion. One of the best studied the fate of transfected cells, an excess of Bcl-2 resulting
survival genes is bcl-2, the first member identified of a in survival but an excess of Bax resulting in death. How-
growing family of genes that participate in the control ever, a simple agonist-antagonist relationship between
of apoptosis. The bcl-2 gene family contains both anti- the pro-apoptotic and anti-apoptotic family members
apoptotic and pro-apoptotic members (for review, see is complicated by the observation that pairs of anti-
Yang and Korsmeyer, 1996). To date, most studies in- apoptotic members, such as Bcl-2 and Bcl-xL, can also
vestigating the function of these genes have relied on form heterodimers. Furthermore, depending on the
simple overexpression. However, the levels of expres- assay system used, some family members can promote
sion of Bcl-2-related proteins do not always predict the either cell death or cell survival (Kiefer et al., 1995; Cor-
ability of a cell to resist death-promoting stimuli. Such tazzo and Schor, 1996; Middleton et al., 1996). Neverthe-
data have been interpreted as evidence for Bcl-2-inde- less, a model for the regulation of cell survival by Bcl-2
pendent mechanisms of regulating apoptosis (Strasser family proteins has been suggested in which Bax homo-
et al., 1995).
dimers comprise an active trigger for cell death. In the
Several recent experiments have indicated that post-
presence of an excess of Bcl-2 or Bcl-xL, heterodimeri-translational modification of Bcl-2-related proteins may
zation with Bax prevents the formation of toxic Bax
play an important role in regulating their ability to pro-
homodimers, resulting in survival. The additional pres-mote cell survival. First, the ability of the chemothera-
ence of Bad would then disrupt Bcl-2–Bax and Bcl-peutic agent taxol to induce phosphorylation of Bcl-2
xL–Bax heterodimers, liberating Bax once again to self-has been implicated as a mechanism by which it can
dimerize and promote death. However, in an equallypromote death in the face of high expression of Bcl-2
plausible model, Bcl-2 and Bcl-xL might beactive repres-(Haldar et al., 1995). Consistent with this observation,
sors of cell death, and dominant heterodimerization withdeletion of a putative negative regulatory loop that con-
Bax or Bad may block the ability of the former moleculestains the major serine/threonine phosphorylation sites
to prevent apoptosis. In favor of this model is the obser-in Bcl-2 enables Bcl-2 to promote cell survival under
vation that specific mutations in Bcl-xL that abrogateconditions where it is normally inactive (Chang et al.,
binding to Bax do not eliminate the ability of Bcl-xL to1996). Second, Bcl-2 appears to be cleaved by prote-
prevent death (Cheng et al., 1996).ases activated during apoptosis, which may explain the
One common feature of most Bcl-2-related proteinsdeath of lymphocytes infected with HIV (Strack et al.,
is a carboxy-terminal hydrophobic domain. In Bcl-2 and1996). Two papers in the current issue of Cell demon-
Bcl-xL, at least, this domain is responsible for their local-strate a third mechanism for post-translational modifica-
ization to the endoplasmic reticulum, the outer mito-tion, serine-phosphorylation of the pro-apoptotic Bcl-2
chondrial membrane, and the outer nuclear membrane.family member, Bad. These observations have opened
An exception is the death-promoting relative Bad, whichan avenue of investigation into the signal transduction
lacks a carboxy-terminal hydrophobic stretch, sug-cascades triggered by extracellular survival signals that
gesting that it is not an integral membrane protein.can modify the function of Bcl-2 family proteins.
Growth Factors Induce Survival SignalsBcl-2 Protects against Death
Several growth factors originally characterized for theirOverexpression of Bcl-2 in cytokine-dependent cell lines
ability to induce proliferation have been shown to beenhances cell survival following growth factor with-
potent regulators of cell survival (Harrington et al., 1994).drawal, a property that first implicated Bcl-2 as a regula-
For example, the cytokines IL-2, IL-4, and IL-7 promotetor of apoptosis rather than as a growth-promoting on-
cogene (Yang and Korsmeyer, 1996). Bcl-2 protects a the survival of resting T cells that do not proliferate in
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By selectively focusing on specific signaling path-Table 1. Bcl-2-Related Proteins
ways, cytokine-induced growth signals have been sepa-
Family
rated from those that induce survival in some modelMember Anti-apoptotic Pro-apoptotic
systems. For instance, the tyrosine kinase inhibitor gen-
Mcl-1 1 istein has been reported to inhibit IL-3-driven prolifera-
NR-13 1
tion but not IL-3-facilitated survival. In the same cells,A1 1
a truncated GM-CSF receptor that fails to activate RasBcl-w 1
and Raf-1 promotes transient DNA synthesis in re-Bcl-xL 1
Bcl-2 1 1 sponse to GM-CSF but does not sustain cell survival
(Kinoshita et al., 1995). These observations suggest thatBax 1 1
Bak 1 1 Ras, Raf-1, or both can play an important role in trans-
Bad 1 ducing survival signals in some experimental systems.
Phosphorylation of Bcl-2The Bcl-2 family consists of proteins that share a common domain
of approximately 66 amino acids, comprising the Bcl-2 homology The relationship between Bcl-2 function and the known
regions 1 and2 (BH1 andBH2). Paradoxically, a given family member pathways of receptor-mediated signal transduction is
may perform either function, depending on the cell system utilized not clear. Bcl-2 is phosphorylated on serine residues in
(Kiefer et al., 1995; Cortazzo and Schor, 1996; Middleton et al., 1996).
response to a variety of stimuli (May et al., 1994; HaldarFunctional outcome may correlate with the ability to dimerize with
et al., 1995; Chen and Faller, 1996). Although the func-specific other family members, or with how extracellular signals
tion of this phosphorylation is controversial, several ob-regulate phosphorylation. The family members listed are those for
which functional data have been published. servations suggest that Bcl-2 can be inactivated by
phosphorylation (Figure 1). Follicular lymphoma cells
with a t(14;18) translocation do not contain phosphory-response to these signals. GM-CSF and IL-3 promote
lated Bcl-2. Treatment of lymphoid cellswith the chemo-the survival of myeloid cells, while erythropoietin facili-
therapeutic drug taxol or the phosphatase inhibitor oka-tates survival of the erythroid lineage. Similarly, IGF-1
daic acid induces phosphorylation of Bcl-2 and resultsaugments the survival of fibroblasts, and NGF and CNTF
in cell death. In addition, Bcl-2 is phosphorylated in thecan foster the survival of neuronal cell lines. For the
pre-B cell line WEHI-231, a system in which Bcl-2 doesmost part, exposure to these factors does not appear
not protect well against apoptosis. Interestingly, phos-to modulate the expression of Bcl-2.
phorylation of Bcl-2 appears to depend upon the pres-At least two signal transduction mechanisms have
ence of a flexible loop domain. Deletion of the loopbeen found to be activated in response to growth fac-
domain results in marked augmentation in the protectivetors, one dependent on tyrosine kinases and the other
effect of Bcl-2 (Chang et al., 1996). Thus, the loop do-initiated by the guanine nucleotide binding protein, Ras.
main may have a negative-regulatory function that isRas is a GTPase-containing protein that is active when
dependent upon serine phosphorylation, which in turnin a GTP-bound state and inactive when the bound GTP
may attenuate the protective effect of Bcl-2.is hydrolyzed to GDP. It is localized to the inner aspect
Bcl-2 has been reported to coimmunoprecipitate withof the plasma membrane via a farnesylation sequence
Raf-1 (Wang et al., 1994), although it is likely that thisat its carboxy terminus. One role of activated Ras is to
interaction is indirect. However, Raf-1 does not appearrecruit other enzymes to the plasma membrane, pre-
tophosphorylate Bcl-2 directly, and Bcl-2 also can asso-sumably to bring them into proximity with key activators
ciate with a kinase-dead variant of Raf-1. Thus, the ki-and substrates. The serine/threonine kinase Raf-1 is the
nase responsible for phosphorylation of Bcl-2 remainsbest characterized downstream Ras effector (Morrison,
to be elucidated. Interaction of Bcl-2 with p21Ras (Chen1995). Targeting Raf-1 itself to the membrane by intro-
and Faller, 1996) and with p23R-Ras also has been re-duction of a farnesylation sequence can bypass a need
for activated Ras. ported.
Figure 1. Model for theFunctional Relevance
of Serine Phosphorylation of Bcl-2
Most data are consistent with a negative reg-
ulatory role for Bcl-2 phosphorylation, which
lowers the apoptotic threshold and promotes
cell death despite the presence of Bcl-2.
However, the phosphorylation sites on Bcl-2
have not been mapped in all systems, and it
remains possible that distinct phosphoryla-
tion sites may regulate Bcl-2 function differ-
ently. In addition to the outer mitochondrial
membrane, Bcl-2 also distributes to the en-
doplasmic reticulum and outer nuclear mem-
brane.
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Phosphorylation of Bad
A role for the phosphorylation of Bcl-2-related proteins
has nowbeen extended to Bad, a pro-apoptotic member
of the Bcl-2 family. Zha and colleagues (1996, this issue)
have demonstrated that Bad is phosphorylated on ser-
ine residues in response to IL-3, and becomes dephos-
phorylated upon growth factor withdrawal. Interestingly,
nonphosphorylated Bad associates with Bcl-xL in coim-
munoprecipitation experiments. Phosphorylation of Bad
renders it unable to bind to Bcl-xL. Instead, the phos-
phorylated form of Bad associates with 14-3-3, a protein
that interacts with several signaling enzymes including
Raf-1, apparently through a binding pocket for serine-
phosphorylated sequences (Muslin et al., 1996). Indeed,
Bad contains a phosphorylation-dependent consensus
sequence for 14-3-3 recognition. The Bad–14-3-3 com-
plex appears to reside in the cytosol, thus preventing
the interaction of Bad with Bcl-xL at the mitochondrial
membrane. Transfection with a mutant Bad in which the
regulatory serine phosphorylation sites were substituted
results in a failure to bind 14-3-3 and accelerates
apoptosis upon IL-3 withdrawal. These observations
suggest that one mechanism by which growth factors
promote survival is through the ability to induce the
phosphorylation of Bad, resulting in its association with
14-3-3 (Figure 2A). This sequesters Bad away from Bcl-
xL, thus freeing Bcl-xL to exert its anti-apoptotic effect.
In contrast, growth factor withdrawal may promote
apoptosis as a result of dephosphorylation of Bad, either
Figure 2. Models for the Phosphorylation of Badthroughnatural decay or via the action of a phosphatase,
In (A), a putative kinase activated by growth factor engagementallowing it to dimerize with Bcl-xL.
phosphorylates Bad, which prevents it from interacting with Bcl-xL.Which Kinases Are Involved?
This frees Bcl-xL to execute its anti-apoptotic function (Zha et al.,Although Raf-1 can phosphorylate Bad in vitro, the sites
1996). The ability of phosphorylated versus nonphosphorylated Bad
of phosphorylation are distinct from those modified by to interact with Bcl-2 has not been reported. In (B), Raf-1 is translo-
IL-3 exposure in vivo (Zha et al., 1996). Nevertheless, cated to Bcl-2 at the mitochondria, initiating a local signaling cas-
using a fusion protein between the catalytic domain of cade resulting in the serine phosphorylation of Bad. Presumably,
these events can be induced by exposure to a growth factor suchRaf-1 and green fluorescent protein, Wang and col-
as IL-3 (Wang et al., 1996).leagues have found that overexpression of Bcl-2 can
induce the localization of Raf-1 to mitochondria (Wang
et al., 1996, this issue). By analogy to the approach of
would occur independently from Ras, since the Raf-1farnesylation to target Raf-1 to the plasma membrane,
construct employed lacks the Ras binding domain. Fur-Wang et al. targeted Raf-1 to mitochondria by fusing it
thermore, other studies by this group indicate that Bcl-to the transmembrane domain of the yeast outer mito-
2–Raf-1 interactions do not modulate Raf-1 kinase activ-chondrial membrane protein, Mas70p. Transfection of
ity (Wang et al., 1994).IL-3-dependent cells with this construct renders them
If Raf-1 is not directly responsible for serine phosphor-resistant to death upon growth factor withdrawal, even
ylation of Bcl-2 or Bad, then which kinases are? Within the absence of Bcl-2 overexpression. This effect de-
respect to Bcl-2, the fact that signaling events leadingpends on an active Raf-1 kinase, as mitochondrial tar-
to the activation of stress-induced kinases Jnk and p38geting of a kinase-dead mutant augments death, per-
can promote cell death (Xia et al., 1995) suggests thathaps by interfering with endogenous Raf-1 function.
participants in these pathways may phosphorylateThus, one role of Bcl-2 may be to target Raf-1 to the
Bcl-2. For Bad, although its phosphorylation is inducedouter mitochondrial membrane, bringing it into proximity
by PMA and inhibited by staurosporine, PKC does notwith a specific set of substrates. In the studies of Wang
appear to phosphorylate Bad at the correct site in vitroet al. mitochondrial localization of Raf-1 is necessary
(Zha et al., 1996). Heart muscle kinase does phosphory-for it to induce Bad phosphorylation. However, the data
late Bad at the correct site, suggesting that a PKA-of Zha and colleagues suggest that Raf-1 probably does
related kinase might operate in vivo. However, it is plau-not directly phosphorylate Bad. If both groups are cor-
sible to consider that the kinase that phosphorylatesrect, then Raf-1 translocation to the mitochondria may
Bad is downstream from Raf-1 but does not participateinitiate a local signaling cascade that leads secondarily
in the cascade leading to Erk activation. Although theto Bad phosphorylation (Figure 2B).
only known physiologic substrate for Raf-1 is MEK, evi-One limitation of the studies of Wang and colleagues
dence in multiple systems suggests that additional Raf-1is the lack of a mechanism for how IL-3-mediated signal
substrates exist, one of which could be a kinase capabletransduction might promote Raf-1 recruitment to the
mitochondrial membrane by Bcl-2. This presumably of phosphorylating Bad.
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Conclusions that regulate those enzymes, and the role of these sig-
naling events in the control of cell survival in responseThe mechanism by which Bcl-2 and Bcl-xL promote cell
to diverse extracellular ligands.survival is not yet understood. However, the establish-
ment of functional links to signal transduction events
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2B). Ligation of growth factor receptors could promote
Muslin, A.J., Tanner, J.W., Allen, P.M., and Shaw, A.S. (1996). Cell
Raf-1 translocation to the outer mitochondrial mem- 84, 889–897.
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dimerize and form a membrane pore that is regulated
by pH. By analogy, Bcl-xL and Bcl-2 may form a pore
involved in the homeostasis of cellular organelles, par-
ticularly of the mitochondria, that may protect cells
against electrochemical changes that occur under
stressful physiologic conditions. Bad might interfere
with the assembly or the function of such pores, thus
eliminating the ability of Bcl-2 and Bcl-xL to protect cells
against death.
In summary, although protection of cells against
apoptotic death can be influenced by the levelof expres-
sion of Bcl-2 and Bcl-xL, post-translational modification
of Bcl-2 family members appears to be important as
well. In the situations reported to date, phosphorylation
appears to be inhibitory. Phosphorylation of Bcl-2 on
serine residues appears to inhibit its anti-apoptotic func-
tion. Serine phosphorylation of Bad results in its binding
to 14-3-3 rather than to Bcl-xL, thus blocking the pro-
apoptotic function of Bad. Further investigation will be
required to identify the kinases and phosphatases that
directly modulate Bcl-2 and Bad, the signaling pathways
